Christian Dior Se · EURONEXT:CDI
Christian Dior — Shareholder Meeting (June 2020)
26 slides from Christian Dior's shareholder meeting presentation, Jun 30, 2020
Slide 1: Combined Shareholders' Meeting
COMBINED SHAREHOLDERS’ MEETING JUNE 30, 2020
Slide 2: Contents
CONTENTS INTRODUCTION Page 3 CONSOLIDATED FINANCIAL STATEMENTS AS OF DECEMBER 31, 2019 Page 4 THE GROUP FACING COVID-19 Page 11 Q1 2020 REVENUE Page 12 DIVIDEND PROPOSAL IN RESPECT OF FISCAL YEAR 2019 Page 13 Note: As table totals are calculated based on unrounded figures, there may be discrepancies
Slide 3: Excellent Performance in 2019
EXCELLENT PERFORMANCE IN 2019 - Buoyant market despite uncertain geopolitical context - Good progress in all geographic regions - Another record year with double-digit increases in revenue and profit from recurring operations - Healthy financial position - Integration of the Belmond hotel group - Ag
Slide 4: Consolidated Revenue for Fiscal Year 2019
CONSOLIDATED REVENUE FOR FISCAL YEAR 2019 In millions of euros Currency Structure Organic effect impact growth 53,670 46,826 +3% +1% +10% +15% 2018 2019 4
Slide 5: Revenue by Business Group
REVENUE BY BUSINESS GROUP In millions of euros Reported Organic FY 2019 FY 2018 growth growth (*) Wines and Spirits 5 576 5 143 +8% +6% Champagne & Wines 2 507 2 369 +6% +4% Cognac & Spirits 3 069 2 774 +11% +7% Fashion and Leather Goods 22 237 18 455 +20% +17% Perfumes and Cosmetics 6 835 6 092 +12
Slide 6: Condensed Consolidated Income Statement
CONDENSED CONSOLIDATED INCOME STATEMENT In millions of euros 2019 (*) 2018 % Change REVENUE 53 670 46 826 15% GROSS MARGIN 35 547 31 201 14% Marketing and selling expenses (20 206) (17 752) 14% General and administrative expenses (3 877) (3 471) 12% Income/(loss) from joint ventures and associates 2
Slide 7: Profit from Recurring Operations by Business Group
PROFIT FROM RECURRING OPERATIONS BY BUSINESS GROUP In millions of euros (*) Reported FY 2019 FY 2018 growth Wines and Spirits 1 729 1 629 +6% Champagne & Wines 690 649 +6% Cognac & Spirits 1 039 980 +6% Fashion and Leather Goods 7 344 5 943 +24% Perfumes and Cosmetics 683 676 +1% Watches and Jewelry
Slide 8: Consolidated Cash Flow
CONSOLIDATED CASH FLOW FISCAL YEAR 2019 (*) In millions of euros 2019 2018 CASH FROM OPERATIONS BEFORE CHANGES 16 092 11 944 IN WORKING CAPITAL Interest paid on net financial debt (137) (130) Interest paid on lease liabilities (239) - Tax paid on operating activities (2 845) (2 308) Change in workin
Slide 9: Consolidated Financial Structure
CONSOLIDATED FINANCIAL STRUCTURE DECEMBER 31, 2019 (*) In billions of euros 93.8 93.8 38% Total equity 35.7 Non-current 71% 66.9 assets 38% Non-current 35.5 liabilities 15% Inventories 13.7 14% 22.7 24% Current Other current liabilities assets 13.2 Assets Liabilities and equity (*) Incorporating for
Slide 10: Total Equity and Net Financial Debt
TOTAL EQUITY AND NET FINANCIAL DEBT In billions of euros DECEMBER 31, 2017 DECEMBER 31, 2018 DECEMBER 31, 2019 (*) 6% 1% 17% 32.7 36.4 35.7 6.2 2.0 0.4(****) TOTAL EQUITY (**) NET FINANCIAL DEBT (***) GEARING (*) Incorporating for the first time the effects of the application of IFRS 16 Leases. (**)
Slide 11: The Group Facing COVID-19
THE GROUP FACING COVID-19 - Absolute priority given to health and safety of our employees and customers - Direct support to fight the epidemic, worldwide • Help for caregivers • Manufacture of hydroalcoholic gel; assistance with routing and production of masks • Equipment search for hospitals • Fina
Slide 12: Consolidated Revenue for Q1 2020
CONSOLIDATED REVENUE FOR Q1 2020 In millions of euros Currency Structure Organic effect impact growth 12,538 10,596 +1% +1% -17% -15% Q1 2019 Q1 2020 12
Slide 13: Dividend Proposal in Respect of Fiscal Year 2019
DIVIDEND PROPOSAL IN RESPECT OF FISCAL YEAR 2019 (3RD RESOLUTION) Gross amount: ordinary dividend of €4.80 per share (vs. €6.00 per share in respect of fiscal year 2018) and exceptional dividend of €29.20 per share, for a total dividend of €34.00 per share - Ordinary dividend component lower within
Slide 14: Statutory Auditors' Reports
STATUTORY AUDITORS’ REPORTS JUNE 30, 2020
Slide 15: Statutory Auditors' Reports
STATUTORY AUDITORS’ REPORTS ORDINARY – Report on the parent company financial statements SHAREHOLDERS’ – Report on the consolidated financial statements MEETING – Special report on regulated related-party agreements EXTRAORDINARY SHAREHOLDERS’ – 5 special reports on equity-related transactions MEETI
Slide 16: Report on the Parent Company Financial Statements
REPORT ON THE PARENT COMPANY FINANCIAL STATEMENTS (1ST RESOLUTION) – Pages 294 to 296 of the Annual Report – No key audit matters – In our opinion, the parent company financial statements give a true and fair view of the Company’s assets, liabilities and financial position as of December 31, 2019 an
Slide 17: Report on the Consolidated Financial Statements
REPORT ON THE CONSOLIDATED FINANCIAL STATEMENTS (2ND RESOLUTION) – Pages 271 to 275 of the Annual Report – Key audit matters: • Valuation of fixed assets, in particular intangible assets • Valuation of inventories and work in progress • Provisions for contingencies, losses and uncertain tax position
Slide 18: Special Report on Regulated Related-Party Agreements
SPECIAL REPORT ON REGULATED RELATED-PARTY AGREEMENTS (4TH RESOLUTION) Pages 297 to 298 of the Annual Report The new related-party agreement submitted for approval – which received prior approval from your Board of Directors in 2019 – relates to a specific assignment given to an ad-hoc committee comp
Slide 19: Special Reports on Equity-Related Transactions
SPECIAL REPORTS ON EQUITY-RELATED TRANSACTIONS (PROVIDED SEPARATELY FROM THE ANNUAL REPORT) Delegation of authority / Authorizations to be granted to the Board of Directors Authorization to reduce the share capital by retiring shares held by the Company 15th resolution Authorization to issue shares
Slide 20: Special Reports on Equity-Related Transactions
SPECIAL REPORTS ON EQUITY-RELATED TRANSACTIONS (PROVIDED SEPARATELY FROM THE ANNUAL REPORT) Delegation of authority / Authorizations to be granted to the Board of Directors Delegation of authority to be granted to the Board of Directors to issue shares and/or other securities giving access to the Co
Slide 21: Questions & Answers
QUESTIONS & ANSWERS JUNE 30, 2020
Slide 22: Vote on the Resolutions
VOTE ON THE RESOLUTIONS JUNE 30, 2020
Slide 23: Voting Results for Each Resolution
VOTING RESULTS FOR EACH RESOLUTION Ordinary resolutions For Against Abstain 1 Approval of the parent company financial statements >99.999% <0.001% 0.001% 2 Approval of the consolidated financial statements >99.999% <0.001% 0.001% 3 Allocation of net profit – Determination of dividend 99.993% 0.007%
Slide 24: Voting Results for Each Resolution
VOTING RESULTS FOR EACH RESOLUTION Extraordinary resolutions For Against Abstain 15 Authorization to be granted to the Board of Directors, for a period of 18 months, to reduce the share capital by retiring shares held by the Company subsequent to a repurchase of its own shares 99.990% 0.010% 0.001%
Slide 25: Voting Results for Each Resolution
VOTING RESULTS FOR EACH RESOLUTION Extraordinary resolutions For Against Abstain 22 Delegation of authority to be granted to the Board of Directors, for a period of 26 months, to issue shares and/or equity securities giving access to other equity securities or that confer rights to the allocation of
Slide 26: Combined Shareholders' Meeting
COMBINED SHAREHOLDERS’ MEETING JUNE 30, 2020 This document is a free translation into English of the original French slideshow. It is not a binding document. In the event of a conflict in interpretation, reference should be made to the French version, which is the authentic text.